Methods for identifying small molecules that modulate...

Details Methods for identifying small molecules that modulate... Methods for identifying small molecules that modulate...

2011-04-19

2011-04-19

Vogel, Nancy (Department: 1636)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving nucleic acid

C536S023100

Reexamination Certificate

active

07927791

ABSTRACT:
The present invention relates to a method for screening and identifying compounds that modulate premature translation termination and/or nonsense-mediated messenger ribonucleic acid (“mRNA”) by interacting with a preselected target ribonucleic acid (“RNA”). In particular, the present invention relates to identifying compounds that bind to regions of the 28S ribosomal RNA (“rRNA”) and analogs thereof. Direct, noncompetitive binding assays are advantageously used to screen libraries of compounds for those that selectively bind to a preselected target RNA. Binding of target RNA molecules to a particular compound is detected using any physical method that measures the altered physical property of the target RNA bound to a compound. The structure of the compound attached to the labeled RNA is also determined. The methods used will depend, in part, on the nature of the library screened. The methods of the present invention provide a simple, sensitive assay for high-throughput screening of libraries of compounds to identify pharmaceutical leads.

REFERENCES:
patent: 4668625 (1987-05-01), Cambiaghi et al.
patent: 5015570 (1991-05-01), Scangos et al.
patent: 5510240 (1996-04-01), Lam et al.
patent: 5593835 (1997-01-01), Rando et al.
patent: 5641627 (1997-06-01), Moehle
patent: 5650316 (1997-07-01), Aggarwal et al.
patent: 5663317 (1997-09-01), Falkow et al.
patent: 5666341 (1997-09-01), Horibe et al.
patent: 5667975 (1997-09-01), Dykstra et al.
patent: 5679566 (1997-10-01), He et al.
patent: 5712096 (1998-01-01), Stern et al.
patent: 5716825 (1998-02-01), Hancock et al.
patent: 5721099 (1998-02-01), Still et al.
patent: 5804563 (1998-09-01), Still et al.
patent: 5807682 (1998-09-01), Grossman et al.
patent: 5837449 (1998-11-01), Ecker et al.
patent: 5840702 (1998-11-01), Bedwell
patent: 5866341 (1999-02-01), Spinella et al.
patent: 5871923 (1999-02-01), Moehle
patent: 6004749 (1999-12-01), Giordano et al.
patent: 6060240 (2000-05-01), Kamb et al.
patent: 6071700 (2000-06-01), He et al.
patent: 6090912 (2000-07-01), Lebl et al.
patent: 6107029 (2000-08-01), Giordano
patent: 6147344 (2000-11-01), Annis et al.
patent: 6207391 (2001-03-01), Wu et al.
patent: 6211477 (2001-04-01), Cardott et al.
patent: 6232075 (2001-05-01), Williams
patent: 6320040 (2001-11-01), Cook et al.
patent: 6329146 (2001-12-01), Crooke et al.
patent: 6355428 (2002-03-01), Schroth et al.
patent: 6391542 (2002-05-01), Anderson et al.
patent: 6458538 (2002-10-01), Beckman et al.
patent: 6503713 (2003-01-01), Rana
patent: 6503721 (2003-01-01), Arenas et al.
patent: 6596481 (2003-07-01), Rothschild et al.
patent: 6875736 (2005-04-01), Rana et al.
patent: 6992096 (2006-01-01), Karp et al.
patent: 7026122 (2006-04-01), Beckmann et al.
patent: 7291461 (2007-11-01), Welch et al.
patent: 7354709 (2008-04-01), Yang et al.
patent: 2003/0232360 (2003-12-01), Wilusz et al.
patent: 2004/0067900 (2004-04-01), Wilde et al.
patent: 2004/0162345 (2004-08-01), Berger et al.
patent: 2004/0219545 (2004-11-01), Rando et al.
patent: 2005/0142545 (2005-06-01), Conn et al.
patent: 2005/0221368 (2005-10-01), Rana et al.
patent: 2006/0134681 (2006-06-01), Beckmann et al.
patent: 2006/0166926 (2006-07-01), Wilde et al.
patent: 2006/0167065 (2006-07-01), Wilde et al.
patent: 2006/0167263 (2006-07-01), Wilde et al.
patent: 2006/0194234 (2006-08-01), Conn et al.
patent: 2006/0228730 (2006-10-01), Rando et al.
patent: 1 218 544 (2001-04-01), None
patent: 1 238 110 (2001-06-01), None
patent: 1 377 684 (2002-10-01), None
patent: 1 543 157 (2005-06-01), None
patent: 2 036 991 (2009-03-01), None
patent: WO 95/05389 (1995-02-01), None
patent: WO 96/22301 (1996-07-01), None
patent: WO 97/09342 (1997-03-01), None
patent: WO 99/20797 (1999-04-01), None
patent: WO 99/24595 (1999-05-01), None
patent: WO 99/45150 (1999-09-01), None
patent: WO 00/03240 (2000-01-01), None
patent: WO 00/09464 (2000-02-01), None
patent: WO 01/25486 (2001-04-01), None
patent: WO 01/44516 (2001-06-01), None
patent: WO 02/083837 (2002-10-01), None
patent: WO 02/083953 (2002-10-01), None
patent: WO 2004/010106 (2004-01-01), None
patent: WO 2004/091502 (2004-10-01), None
patent: WO 2005/086768 (2005-09-01), None
patent: WO 2006/044456 (2006-04-01), None
Shiroki et al., Methods in Molecular Biology, 118, 449-458, 1999.
Gorski et al.(J. Mol. Evol., 1987, 24:236-251).
Aboul-Ela et al., “The structure of the human immunodeficiency virus type-1 TAR RNA reveals principles of RNA recognition by Tat protein.”J. Mol. Biol. 1995; 253:313-332.
Aggarwal et al., “Triple helix-forming oligodeoxyribonucleotides targeted to the human tumor necrosis factor, TNF, gene inhibit TNF production and block the TNF-dependent growth of human glioblastoma tumor cells.”Cancer Res. 1996; 56:5156-5164.
Andreutti-Zaugg, C. et al., “Inhibition of nonsense-mediated messenger RNA decay in clinical samples facilitates detection of human MSH2 mutations with an in vivo fusion protein assay and conventional techniques,”Cancer Research1997; 57(15): 3288-3293.
Bakheet et al., “ARED: human AU-rich element-containing mRNA database reveals an unexpectedly diverse functional repertoire of encoded proteins.”Nucleic Acids Res. 2001; 29:246-254.
Barton-Davis et al., “Animoglycoside antibiotics restore dystrophin function to skeletal muscles ofmdxmice”Journal of Clinical InvestigationAug. 1999; 104(4): 375-381.
Bateman J.F. et al., “Reliable and sensitive detection of premature termination mutations using a protein truncation test designed to overcome problems of nonsense-mediated mRNA instability.”Human Mutation1999; 13(4): 311-317.
Bayer, “Towards the Chemical Synthesis of Proteins.”Angew. Chem. 1991; 30:113-129.
Beal & Dervan, “Second structural motif for recognition of DNA by oligonucleotide-directed triple-helix formation.”Science1991; 251(4999):1360-1363.
Bedwell et al., “Suppression of a CFTR premature stop mutation in a bronchial epithelial cell line.”Nature MedicineNov. 1997; 3(11): 1280-1284.
Blackwell et al., “A one-bead, one-stock solution approach to chemical genetics: part 1.”Chem&Bio. 2001; 8:1167-1182.
Burbaum J.J. & Siga, N.H. et al., “New technologies for high-throughput screening,”Curr. Opin. in Chem. Bio.; 72-78.
Buzina, A. & Shulman, M.J., “Infrequent Translation of a Nonsense Codon is sufficient to decrease mRNA Level.”Molecular Biology of the CellMar. 1999; 10: 515-524.
Carter et al., “A Regulatory mechanism that detects premature nonsense codons in T-cell receptor transcripts in vivo is reversed by protein synthesis inhibitors in vitro”J. Biol. Chem. 1996; 270(48): 28995-29003.
Carter et al., “A splicing-dependent regulatory mechanism that detects translation signals.”The EMBO Journal1996; 15(21): 5965-5975.
Chastain & Tinoco, “Structural elements in RNA.”Prog. Nucleic Acid Res. Mol. Bio. 1991; 41:131-177.
Chow & Bogdan, “A structural basis for RNA-ligand interactions.”Chem. Rev. 1997; 97:1489-1514.
Churcher et al., “High affinity binding of TAR RNA by the human immunodeficiency virus type-1 tat protein requires base-pairs in the RNA stem and amino acid residues flanking the basic region”J. Mol. Biol.1993; 230:90-110.
Clemons et al., “A one-bead, one-stock solution approach to chemical genetics: part 2.”Chem&Bio. 2001; 8:1183-1195.
Cordingley et al., “Sequence-Specific Interaction of Tat Protein and Tat Peptides with the Transactivation-Responsive Sequence Element of Human Immunodeficiency Virus Type 1 in vitro.”Proc. Natl. Acad. Sci. USA1990; 87:8985-8989.
Culbertson, M.R., “Unforeseen consequences for gene expression, inherited genetic disorder and cancer.”TIG Nature MedicineFeb. 1999; 15(2): 74-80.
Cundliffe et al., “How antibiotic-producing organisms avoid suicide.”Ann. Rev. Microbiol. 1989; 43:207-233.
Cundliffe et al., “The Riboso

Affiliated with

Also associated with

Rating

Methods for identifying small molecules that modulate... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods for identifying small molecules that modulate..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for identifying small molecules that modulate... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2691439